TKPHF — TAKEDA PHARMACEUTICAL CO LTD
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1395064 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2027-01-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 1,187,097,000,000 | 795,004,000,000 | 205,322,000,000 | 192,429,000,000 | 15,271,498,000,000 | 418,533,000,000 | 7,854,322,000,000 |
| Jun 2026 | 1,219,900,000,000 | 813,224,000,000 | 201,417,000,000 | 113,197,000,000 | 15,663,271,000,000 | 460,982,000,000 | 8,104,395,000,000 |
| Mar 2026 | 1,094,541,000,000 | 688,837,000,000 | 42,068,000,000 | -368,471,000,000 | 15,511,506,000,000 | 595,054,000,000 | 8,080,857,000,000 |
| Dec 2025 | 1,191,698,000,000 | 790,550,000,000 | 168,822,000,000 | 103,640,000,000 | 15,408,774,000,000 | 654,937,000,000 | 7,764,684,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$879,671,000,000
Investing CF
$-396,589,000,000
Financing CF
$-761,309,000,000
CapEx
$-445,724,000,000
Dividends Paid
$-315,684,000,000
Buybacks
$-1,007,000,000
EPS Diluted TTM
$148.77
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$859,247,000,000
Inventory
$1,441,087,000,000
Receivables
$910,245,000,000
ST Investments
$35,868,000,000
EBIT TTM
$82,580,000,000
Pretax Income TTM
$-2,471,000,000
Interest Exp TTM
$85,051,000,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,618,934,812,672
EBITDA
$1,249,335,967,744
Free Cash Flow
$541,443,883,008
Enterprise Value
$5,133,704,888,320
Total Cash
$460,981,993,472
Total Debt
$5,536,499,105,792
Shares Out
1,596,751,439
Trailing EPS
$-0.68
Book Value
$31.13
ROE
-2.3%
ROA
2.7%
Div Yield
3.58%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 4,505,720,000,000 | 464,451,000,000 | -152,390,000,000 | 15,511,506,000,000 | 8,080,857,000,000 | 7,429,441,000,000 | 1,041,431,000,000 |
| Mar 2025 | 4,581,551,000,000 | 466,370,000,000 | 107,928,000,000 | 14,248,344,000,000 | 7,312,365,000,000 | 6,935,084,000,000 | 1,057,182,000,000 |
| Mar 2024 | 4,263,762,000,000 | 309,901,000,000 | 144,067,000,000 | 15,108,792,000,000 | 7,834,787,000,000 | 7,273,264,000,000 | 716,344,000,000 |
| Mar 2023 | 4,027,478,000,000 | 587,812,000,000 | 317,017,000,000 | 13,957,750,000,000 | 7,603,079,000,000 | 6,354,122,000,000 | 977,156,000,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.81
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.26T | $1415.55 | — |
| JNJ | JOHNSON & JOHNSON | $670.92B | $278.70 | — |
| ABBV | AbbVie Inc. | $517.59B | $292.82 | — |
| MRK | Merck & Co., Inc. | $353.44B | $143.37 | — |
| NVS | NOVARTIS AG | $302.46B | $159.13 | — |
News headlines (Yahoo Finance, 1h cache)
Novavax Eyes New Partnerships as Sanofi Advances COVID-Flu Vaccine Trial
2026-11-17 21:12 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Start Week Sharply Lower in Monday Trading
2026-11-16 15:48 · Yahoo
Iambic Provides Business Updates and Third Quarter 2026 Financial Results
2026-11-16 13:00 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Thursday Trading
2026-11-12 15:44 · Yahoo
Takeda Launches ORZEYFUL™ (oveporexton), the First and Only Medicine of Its Kind for Narcolepsy Type 1 Now Available in the United States
2026-11-12 12:35 · Yahoo
Ginkgo Bioworks Holdings Inc (DNA) Q3 2026 Earnings Call Highlights: Cost Cuts, First Big ...
2026-11-12 05:05 · Yahoo
ADMA Surges 20.9% Post Q3 Earnings: Buy, Sell or Hold the Stock?
2026-11-11 16:41 · Yahoo
Raised Guidance Could Change The Case For Schrödinger Stock (SDGR)
2026-11-07 20:12 · Yahoo
HRMY Q3 Earnings Miss Estimates on Higher Costs Despite Wakix Growth
2026-11-05 18:04 · Yahoo
DNLI Up 7.8% Post Q3 Earnings: Should You Buy, Sell or Hold the Stock?
2026-11-05 18:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.